EDGE
21.2.2021 17:53:06 CET | Business Wire | Press release
SIGN4L, a dynamic provider of agile and adaptive electronic warfare and intelligence (EW&I) solutions, today launched two state-of-the-art solutions that are set to offer a tactical advantage in the missions of tomorrow. V-Protect, a radio frequency (RF) communication jamming system, and NavControl-G, a specialised counter-drone capability, are well positioned to become game-changers in shaping favourable outcomes in an increasingly digitalised defence landscape.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210221005031/en/
The solutions were unveiled at the EDGE pavilion at the ongoing International Defence Exhibition and Conference (IDEX 2021) that runs until 25 February at the Abu Dhabi National Exhibition Centre (ADNEC).
V-Protect is an advanced mobile active and reactive high-power jammer system aimed at helping block common terrestrial RF signal technologies as well as portable satcom equipment, spanning radio, walkie-talkie, mobile and Wi-Fi frequencies. Boasting a counter-improvised explosive device (C-IED) and counter-drone measures, the user-friendly model is to be installed in a standard SUV and offers automatic operability by utilizing 16 channels and high emitting power amplifiers to provide support in enhancing protection range and combatting various threats across the frequency domain.
NavControl-G is a sophisticated transmitter unit designed to help prevent unmanned aerial vehicles (UAVs) from trespassing into specific locations. To help safeguard a sensitive area, the system can emulate GPS signals to generate position and timing inaccuracies, thereby taking control of non-cooperating unmanned vehicles. Encased in a shock-proof container, the system can be seamlessly integrated across multiple configurations - either in fixed locations or deployed on the field when required.
Waleid Al Mesmari, Vice President of Program Management for the Electronic Warfare & Intelligence cluster at EDGE, said: “Electronic warfare and intelligence make up the backbone of modern defence and security systems. SIGN4L is at the frontlines in pioneering breakthrough technologies that help our clients expand their options in a rapidly changing world. By assisting our clients with the management of their complex security and performance requirements, our latest solutions are prime examples of our agile offerings at work that focus energy to obscure, neutralise and attack adversaries.”
SIGN4L brings a startup ethos to designing and producing state-of-art open-architecture digital and RF-based security products and services for governments and businesses in the region. The company has implemented a rigorous cycle of threat analysis, research, and development to monitor, analyse and counter emerging risks. SIGN4L is part of the Electronic Warfare & Intelligence cluster at EDGE, an advanced technology group that ranks among the top 25 military suppliers in the world.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20210221005031/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FuzeBox AI Named Founding Co-Author of SPUR Coalition Technical Committee on Verifying AI Content Use5.10.2026 15:00:00 CEST | Press release
A new technical committee will define how publishers can independently confirm AI companies' reports of content use. FuzeBox AI has been named by the SPUR Coalition, an international nonprofit of 37 news and media organizations, as one of four founding co-authors of its Evidence Profile Technical Committee, adopted Sept. 2, 2026, to draft an evidence profile for SPUR's Content Telemetry standard: a way for publishers to verify AI usage reports without depending on the reporting company's cooperation. Under SPUR's current standard, AI companies self-report their content use. A company that skips reporting leaves no record, and publishers can't check what they do receive. On July 10, 2026, FuzeBox proposed its Verified Provenance Telemetry Standard (VPTS): publishers seed content with detectable markers, then verify their appearance in AI outputs via an auditable ledger, with no change to SPUR's standard. Within 48 hours, three organizations filed related proposals: ProRata on usage magn
Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 14:02:00 CEST | Press release
Special-Edition Korea-Made Skin Care Collection Launches In 40 Markets, Available While Supplies Last Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press release
Broadens GE HealthCare's footprint in the U.S. radiopharmaceutical industry, drives patient access to F18 labeled Positron Emission Tomography (PET) radiopharmaceuticals and enhances exposure to new high-growth areas Pharmaceutical Diagnostics (PDx) continues to partner with other established Contract Manufacturing Organizations (CMOs) to drive and expand patient access to its radiopharmaceutical portfolio, while SOFIE Biosciences continues to supply PET products from other leading radiopharmaceutical providers Provides U.S. rights to FAPI-74, a Phase III pipeline PET radiotracer with pan-cancer imaging potential, aiming to be among the first-to-launch in a large and fast-growing market1 GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subje
Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press release
The installation marks a significant step in the evolution of premium No/Low wines, where preserving aroma and sensory quality has become a defining industry priority. Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking exper
Croma-Pharma Expands Its Portfolio in Canada With saypha® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press release
Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
